Literature DB >> 19418740

Osteoarthritis of the thoracolumbar synovial intervertebral articulations: clinical and radiographic features in 77 horses with poor performance and back pain.

M Girodroux1, S Dyson, R Murray.   

Abstract

REASONS FOR PERFORMING STUDY: Back pain is well recognised as a cause of poor performance in horses, but the role of lesions of the thoracolumbar synovial intervertebral articulations (facet joints) has not been well documented.
OBJECTIVES: To describe the clinical features, radiographic appearance and location of facet joint lesions and determine if there was any breed, gender, age, bodyweight or work discipline predilection.
METHODS: Data from 77 horses examined at the Animal Health Trust January 1997-September 2007 with evidence of thoracolumbar pain and radiographic changes of the facet joints were reviewed. The presence of either other osseous abnormalities of the thoracolumbar region or other problems potentially contributing to poor performance were recorded. Facet joint lesions were graded radiographically and their location determined. Influence of breed, gender and discipline on the presence of lesions, effect of location on the type of lesion and the influence of impinging dorsal spinous processes on the clinical features were assessed using Chi-squared tests.
RESULTS: There was no effect of breed, gender, age or bodyweight on occurrence of facet joint lesions. Showjumpers were significantly less affected than horses from other disciplines. There were commonly 2-5 affected facet joints, usually in the caudal thoracic and cranial lumbar spine (T15-LI). Sclerosis, periarticular new bone and narrowing of the joint space were the most frequent radiographic lesion types. Clinical features were significantly different between horses with and without impinging dorsal spinous processes. Severity of clinical signs was related to the presence of other osseous abnormalities, not the number of facet joints involved or the lesion grade.
CONCLUSIONS: Osteoarthritis of the facet joints of the thoracolumbar spine can occur alone, in horses with back pain, or in association with other osseous abnormalities. POTENTIAL CLINICAL RELEVANCE: Osteoarthritis of the thoracolumbar facet joints probably contributes to back pain, but further investigation of the prevalence of osteoarthritis in horses without clinical signs of back pain is merited.

Entities:  

Mesh:

Year:  2009        PMID: 19418740     DOI: 10.2746/042516408x345099

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  5 in total

Review 1.  Effects of hyaluronic acid combined with anti-inflammatory drugs compared with hyaluronic acid alone, in clinical trials and experiments in osteoarthritis: a systematic review and meta-analysis.

Authors:  Thippaporn Euppayo; Veerasak Punyapornwithaya; Siriwadee Chomdej; Siriwan Ongchai; Korakot Nganvongpanit
Journal:  BMC Musculoskelet Disord       Date:  2017-09-06       Impact factor: 2.362

2.  Clinical investigation of back disorders in horses: A retrospective study (2002-2017).

Authors:  Abubakar Musa Mayaki; Abdul Razak Intan-Shameha; Mohd Adzahan Noraniza; Mazlan Mazlina; Lawan Adamu; Rasedee Abdullah
Journal:  Vet World       Date:  2019-03-12

3.  Characterization of bony changes localized to the cervical articular processes in a mixed population of horses.

Authors:  Kevin K Haussler; Roy R Pool; Hilary M Clayton
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

4.  Clinical assessment and grading of back pain in horses.

Authors:  Abubakar Musa Mayaki; Intan Shameha Abdul Razak; Noraniza Mohd Adzahan; Mazlina Mazlan; Abdullah Rasedee
Journal:  J Vet Sci       Date:  2020-11       Impact factor: 1.672

5.  A comparative study of breed differences in the anatomical configuration of the equine vertebral column.

Authors:  Tijn Jan Pieter Spoormakers; Stefanie Veraa; Elisabeth Anna Maria Graat; Paul René van Weeren; Harold Brommer
Journal:  J Anat       Date:  2021-05-15       Impact factor: 2.610

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.